« Projekte
PallasPalbociclib Collaborative Adjuvant Study
Finanzierung:
Industrie;
Pallas
Palbociclib Collaborative Adjuvant Study

PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer (PALLAS)

Schlagworte

Pallas
Kontakt

weitere Projekte

Die Daten werden geladen ...